- Release Date: 03/02/22 09:32
- Summary: OncoSil approved for Innovation Funding (NUB) in Germany
- Price Sensitive: Yes
- Download Document 211.91KB
- Forums
- ASX - By Stock
- OSL
- Ann: OncoSil approved for Innovation Funding (NUB) in Germany
Ann: OncoSil approved for Innovation Funding (NUB) in Germany
Featured News
Add OSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.001(6.67%) |
Mkt cap ! $35.79M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.8¢ | $59.71K | 7.464M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 2253865 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 12580460 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 2253865 | 0.008 |
65 | 29002167 | 0.007 |
25 | 9826065 | 0.006 |
17 | 15710198 | 0.005 |
9 | 9262824 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 10850452 | 13 |
0.010 | 17800330 | 15 |
0.011 | 9139301 | 17 |
0.012 | 7560752 | 5 |
0.013 | 5349700 | 3 |
Last trade - 10.16am 12/11/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
3DA
AMAERO INTERNATIONAL LTD
Hank Holland, Executive Chairman and CEO
Hank Holland
Executive Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online